Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Atrial Fibrillation

1-methyl-3-isobutylxanthine has been researched along with Atrial Fibrillation in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kirschner Peretz, N1
Segal, S1
Shapira, R1
Shemla, O1
Lukyanenko, Y1
Brosh, I1
Lakatta, EG1
Tsutsui, K1
Yaniv, Y1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Atrial Fibrillation

ArticleYear
Changes in cAMP signaling are associated with age-related downregulation of spontaneously beating atrial tissue energetic indices.
    GeroScience, 2023, Volume: 45, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Animals; Atrial Fibrillation; Cyclic AMP; Down-

2023